John Mendlein

1.4k total citations
18 papers, 762 citations indexed

About

John Mendlein is a scholar working on Molecular Biology, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, John Mendlein has authored 18 papers receiving a total of 762 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 3 papers in Surgery and 3 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in John Mendlein's work include Ion Transport and Channel Regulation (6 papers), RNA Research and Splicing (4 papers) and RNA and protein synthesis mechanisms (3 papers). John Mendlein is often cited by papers focused on Ion Transport and Channel Regulation (6 papers), RNA Research and Splicing (4 papers) and RNA and protein synthesis mechanisms (3 papers). John Mendlein collaborates with scholars based in United States, Hong Kong and Sweden. John Mendlein's co-authors include George Sachs, R J Jackson, E. Rabon, Carin Briving, B. Wallmark, Keith Munson, J. Fryklund, David P. Blakeman, Taylor Feehley and Wha Bin Im and has published in prestigious journals such as Science, Journal of Biological Chemistry and Blood.

In The Last Decade

John Mendlein

18 papers receiving 725 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John Mendlein United States 13 598 164 107 83 54 18 762
Nikolay B. Pestov Russia 15 545 0.9× 68 0.4× 88 0.8× 12 0.1× 74 1.4× 73 771
Thibauld Oullier France 12 510 0.9× 57 0.3× 145 1.4× 42 0.5× 60 1.1× 27 819
Jerry G. Henslee United States 12 298 0.5× 68 0.4× 218 2.0× 11 0.1× 54 1.0× 18 653
Xiaofei Qi China 14 493 0.8× 26 0.2× 106 1.0× 26 0.3× 42 0.8× 61 850
F Langr Czechia 10 229 0.4× 147 0.9× 94 0.9× 34 0.4× 66 1.2× 22 494
Nicola Medici Italy 16 475 0.8× 64 0.4× 188 1.8× 19 0.2× 61 1.1× 33 844
Bernice H. Wong Singapore 14 713 1.2× 109 0.7× 136 1.3× 6 0.1× 166 3.1× 21 1.1k
Miroslaw Lech United States 11 505 0.8× 109 0.7× 47 0.4× 9 0.1× 23 0.4× 17 986
Jean Pierre Bali France 11 279 0.5× 75 0.5× 75 0.7× 22 0.3× 12 0.2× 19 490
Loyal G. Tillotson United States 13 277 0.5× 174 1.1× 152 1.4× 6 0.1× 23 0.4× 23 521

Countries citing papers authored by John Mendlein

Since Specialization
Citations

This map shows the geographic impact of John Mendlein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Mendlein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Mendlein more than expected).

Fields of papers citing papers by John Mendlein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Mendlein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Mendlein. The network helps show where John Mendlein may publish in the future.

Co-authorship network of co-authors of John Mendlein

This figure shows the co-authorship network connecting the top 25 collaborators of John Mendlein. A scholar is included among the top collaborators of John Mendlein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Mendlein. John Mendlein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Feehley, Taylor, et al.. (2023). Drugging the epigenome in the age of precision medicine. Clinical Epigenetics. 15(1). 6–6. 65 indexed citations
2.
Adams, Ryan A., Cátia Fernandes‐Cerqueira, Antonella Notarnicola, et al.. (2019). Serum-circulating His-tRNA synthetase inhibits organ-targeted immune responses. Cellular and Molecular Immunology. 18(6). 1463–1475. 26 indexed citations
3.
Mertsching, Elisabeth, Jeanette Ampudia, Ryan A. Adams, et al.. (2018). Identification of a T cell immunomodulatory domain in histidyl-tRNA synthetase. The Journal of Immunology. 200(Supplement_1). 112.3–112.3. 1 indexed citations
5.
Lo, Wing‐Sze, Elisabeth Gardiner, Zhiwen Xu, et al.. (2014). Human tRNA synthetase catalytic nulls with diverse functions. Science. 345(6194). 328–332. 91 indexed citations
6.
Zhou, Jie, Feng Wang, Zhiwen Xu, et al.. (2014). Secreted Histidyl-tRNA Synthetase Splice Variants Elaborate Major Epitopes for Autoantibodies in Inflammatory Myositis. Journal of Biological Chemistry. 289(28). 19269–19275. 42 indexed citations
8.
Grayson, Paul, et al.. (2009). Stem cell modulators (SCMs): a small molecule and biologic approach to stem cell therapeutics. Drug Discovery Today Therapeutic Strategies. 6(4). 141–145. 1 indexed citations
9.
Durick, Kyle, John Mendlein, & Kleanthis G. Xanthopoulos. (1999). Hunting with Traps: Genome-Wide Strategies for Gene Discovery and Functional Analysis. Genome Research. 9(11). 1019–1025. 23 indexed citations
10.
Hediger, Matthias A., et al.. (1991). Biosynthesis of the cloned intestinal Na+/glucose cotransporter. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1064(2). 360–364. 46 indexed citations
11.
Mendlein, John, et al.. (1990). Calcium binding to the H+,K(+)-ATPase. Evidence for a divalent cation site that is occupied during the catalytic cycle.. Journal of Biological Chemistry. 265(26). 15590–15598. 7 indexed citations
12.
Mendlein, John & George Sachs. (1990). Interaction of a K(+)-competitive inhibitor, a substituted imidazo[1,2a] pyridine, with the phospho- and dephosphoenzyme forms of H+, K(+)-ATPase.. Journal of Biological Chemistry. 265(9). 5030–5036. 53 indexed citations
13.
Mendlein, John & George Sachs. (1989). The substitution of calcium for magnesium in H+,K+-ATPase catalytic cycle. Evidence for two actions of divalent cations. Journal of Biological Chemistry. 264(31). 18512–18519. 14 indexed citations
14.
Hersey, S. J., László Steiner, John Mendlein, E. Rabon, & George Sachs. (1988). SCH28080 prevents omeprazole inhibition of the gastric H+/K+-ATPase. Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology. 956(1). 49–57. 33 indexed citations
15.
Wallmark, B., Carin Briving, J. Fryklund, et al.. (1987). Inhibition of gastric H+,K+-ATPase and acid secretion by SCH 28080, a substituted pyridyl(1,2a)imidazole.. Journal of Biological Chemistry. 262(5). 2077–2084. 197 indexed citations
16.
Im, Wha Bin, David P. Blakeman, John Mendlein, & George Sachs. (1984). Inhibition of (H+ + K+)-ATPase and H+ accumulation in hog gastric membranes by trifluoperazine, verapamil and 8-(N,N-diethylamino)octyl-3,4,5-trimethoxybenzoate. Biochimica et Biophysica Acta (BBA) - Biomembranes. 770(1). 65–72. 50 indexed citations
17.
Jackson, R J, John Mendlein, & George Sachs. (1983). Interaction of fluorescein isothiocyanate with the (H+ + K+)-ATPase. Biochimica et Biophysica Acta (BBA) - Biomembranes. 731(1). 9–15. 78 indexed citations
18.
Rabon, E., John Cuppoletti, Danuta H. Malinowska, et al.. (1983). Proton Secretion by the Gastric Parietal Cell. Journal of Experimental Biology. 106(1). 119–133. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026